Abstract
The clinical presentation of heart disease is different between men and women and this distinction is pivotal for a correct diagnosis and an adequate treatment. However, the definition of symptoms classically associated with heart disease is mainly based on the characteristics of those reported in men. Chest pain or chest discomfort in women are therefore often regarded as “atypical” and these symptoms tend to be misdiagnosed and under- treated. Further, women are less likely to receive appropriate invasive and non invasive investigations. They are less likely to refer for medical help and tend to present late in the process of the cardiovascular disease, with delays in the start of effective treatment. Therefore, a gender-specific assessment of cardiovascular risk is strongly advised for patients presenting with symptoms suggestive of heart disease.
Keywords: Coronary disease, angina, heart disease, women, misdiagnosed, symptomatology, atypical, palpitations, dyspnea, scapula, angiograms, prognosis, dyslipidemia, atherogenic, stratification, diastolic, systolic, intramural
Current Pharmaceutical Design
Title: Gender Differences in the Clinical Presentation of Heart Disease
Volume: 17 Issue: 11
Author(s): Peter Collins, Cristiana Vitale, Ilaria Spoletini and Giuseppe Barbaro
Affiliation:
Keywords: Coronary disease, angina, heart disease, women, misdiagnosed, symptomatology, atypical, palpitations, dyspnea, scapula, angiograms, prognosis, dyslipidemia, atherogenic, stratification, diastolic, systolic, intramural
Abstract: The clinical presentation of heart disease is different between men and women and this distinction is pivotal for a correct diagnosis and an adequate treatment. However, the definition of symptoms classically associated with heart disease is mainly based on the characteristics of those reported in men. Chest pain or chest discomfort in women are therefore often regarded as “atypical” and these symptoms tend to be misdiagnosed and under- treated. Further, women are less likely to receive appropriate invasive and non invasive investigations. They are less likely to refer for medical help and tend to present late in the process of the cardiovascular disease, with delays in the start of effective treatment. Therefore, a gender-specific assessment of cardiovascular risk is strongly advised for patients presenting with symptoms suggestive of heart disease.
Export Options
About this article
Cite this article as:
Collins Peter, Vitale Cristiana, Spoletini Ilaria and Barbaro Giuseppe, Gender Differences in the Clinical Presentation of Heart Disease, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656927
DOI https://dx.doi.org/10.2174/138161211795656927 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Disease and Insulin-Like Growth Factor-1
Vascular Disease Prevention (Discontinued) Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Free Radicals in Diseases and Potential Role of Phytoconstituents-A Cause with Emerging Importance
Current Chemical Biology Serum Levels of IL-6, TNF-α and IL-10 as Early Predictors of Mortality in Trauma Hemorrhagic Shock Patients
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Consumer Understanding and Use of Health Claims: The Case of Functional Foods
Recent Patents on Food, Nutrition & Agriculture Regenerative Approaches to Post-Myocardial Infarction Heart Failure
Current Pharmaceutical Design The Adiponectin Signaling Pathway as a Novel Pharmacological Target
Mini-Reviews in Medicinal Chemistry Role of Mammalian Target of Rapamycin in Atherosclerosis
Current Molecular Medicine NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Calcium Channel Blockers in the Management of Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Successful Radiofrequency Ablation of Atrial Flutter Causing Hemodynamic Instability in a Patient with Recent Myocardial Infarction
Current Cardiology Reviews Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models
Current Drug Targets Application of VEGF Gene Therapy in Two Basic Fields of Plastic- Reparative Surgery: Tissue Reconstruction with Flaps and Peripheral Nerve Surgery
Recent Patents on Regenerative Medicine Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 2018
Current Vascular Pharmacology Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Novel Antiinflammatory and Antiinfective Agents
Anti-Infective Agents in Medicinal Chemistry Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Chronotherapeutic Drug Delivery from Indomethacin Compression Coated Tablets for Early Morning Pain Associated Rheumatoid Arthritis
Current Drug Delivery Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
Current Pharmaceutical Design